Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01667887 · ClinicalTrials.gov registry record
Plating of Distal Femur Fractures by Far Cortical Locking Using MotionLoc Screws
A clinical trial, sponsored by Legacy Biomechanics Laboratory.
- Completed
- Registry status
- 33
- Enrollment target
NCT01667887: Completed study, sponsored by Legacy Biomechanics Laboratory.
NCT01667887 is a clinical trial that has completed, run by Legacy Biomechanics Laboratory. The registered enrollment target is 33 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01667887 has completed, sponsored by Legacy Biomechanics Laboratory.
- COMPLETED
- Registry status
- 33 participants
- Enrollment target
Study Summary
The objective of this study is to document callus formation and healing of fractures stabilized with locking plates utilizing modern MotionLoc screws that provide controlled axial micro-motion to actively promote fracture healing.
Primary Outcome
Fracture healing is defined clinically by the ability of pain-free weight bearing, and radiographically by callus formation and bridging.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2011-04 |
| Est. Completion | 2013-01 |
What the finished NCT01667887 record still lists
NCT01667887 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 33 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01667887 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01667887 about?
NCT01667887 is a clinical study titled "Plating of Distal Femur Fractures by Far Cortical Locking Using MotionLoc Screws". The objective of this study is to document callus formation and healing of fractures stabilized with locking plates utilizing modern MotionLoc screws that provide controlled axial micro-motion to actively promote fracture healing.
What is the current status of trial NCT01667887?
This trial is currently completed. The enrollment target is 33 participants. The study started on 2011-04. Estimated completion is 2013-01.
Who is sponsoring clinical trial NCT01667887?
This trial is sponsored by Legacy Biomechanics Laboratory, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02861898 · 33 participants · Phase 1
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
- NCT04871607 · 33 participants · Phase 2
Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma
- NCT05071937 · 33 participants · Phase 2
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
- NCT05168618 · 33 participants · Phase 2
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia